CD44 and nonpapillary renal cell carcinoma: Regarding non-ccRCC cases, of all samples stained for CD44, MMP-2 and MMP-9, 11 (18.64%), 9 (15.25%) and 24 (40.68%) samples did not show any staining, respectively.